Fresenius Medical Care AG (FMS): Price and Financial Metrics
GET POWR RATINGS... FREE!
FMS POWR Grades
- FMS scores best on the Stability dimension, with a Stability rank ahead of 99.21% of US stocks.
- FMS's strongest trending metric is Growth; it's been moving down over the last 31 weeks.
- FMS ranks lowest in Growth; there it ranks in the 24th percentile.
FMS Stock Summary
- With a market capitalization of $23,992,448,614, Fresenius Medical Care AG & Co KGaA has a greater market value than 89.77% of US stocks.
- With a year-over-year growth in debt of 66.23%, Fresenius Medical Care AG & Co KGaA's debt growth rate surpasses 88.14% of about US stocks.
- The volatility of Fresenius Medical Care AG & Co KGaA's share price is greater than that of merely 7.87% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Fresenius Medical Care AG & Co KGaA, a group of peers worth examining would be WAB, IEX, HRL, IP, and HIG.
- FMS's SEC filings can be seen here. And to visit Fresenius Medical Care AG & Co KGaA's official web site, go to www.freseniusmedicalcare.com.
FMS Valuation Summary
- FMS's EV/EBIT ratio is 17; this is 36.33% lower than that of the median Healthcare stock.
- FMS's price/sales ratio has moved up 0.9 over the prior 243 months.
- FMS's EV/EBIT ratio has moved up 7.9 over the prior 243 months.
Below are key valuation metrics over time for FMS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| FMS | 2021-04-05 | 1.2 | 1.9 | 18.6 | 15.9 |
| FMS | 2020-07-14 | 1.4 | 2.1 | 21.0 | 18.1 |
| FMS | 2018-06-05 | 1.7 | 3.2 | 24.2 | 17.6 |
| FMS | 2010-03-10 | 1.4 | 2.4 | 18.0 | 12.5 |
| FMS | 2009-06-18 | 1.2 | 2.2 | 15.9 | 11.1 |
| FMS | 2002-12-05 | 0.2 | 0.4 | 3.6 | 7.5 |
FMS Growth Metrics
- Its 4 year price growth rate is now at -16.51%.
- The 3 year price growth rate now stands at -0.19%.
- Its 3 year revenue growth rate is now at -2.42%.
The table below shows FMS's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2020-12-31 | 17,859.06 | 4,233.156 | 1,164.377 |
| 2019-12-31 | 17,476.56 | 2,566.951 | 1,199.619 |
| 2018-12-31 | 16,546.87 | 2,061.911 | 1,981.924 |
| 2018-12-31 | 16,546.87 | 2,061.911 | 1,981.924 |
| 2017-12-31 | 17,783.57 | 2,191.811 | 1,279.788 |
| 2016-12-31 | 17,910.79 | 2,139.882 | 1,243.267 |
FMS Stock Price Chart Interactive Chart >
FMS Price/Volume Stats
| Current price | $38.42 | 52-week high | $44.94 |
| Prev. close | $39.32 | 52-week low | $33.84 |
| Day low | $38.08 | Volume | 460,245 |
| Day high | $38.57 | Avg. volume | 348,115 |
| 50-day MA | $40.95 | Dividend yield | 1.45% |
| 200-day MA | $39.80 | Market Cap | 22.51B |
Fresenius Medical Care AG (FMS) Company Bio
Fresenius Medical Care provides dialysis care services related to the dialysis treatment a patient receives with end stage renal disease, and other health care services. The company was founded in 1996 and is based in Bad Homburg, Germany.
FMS Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $38.42 | $302.6 | 635% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Fresenius Medical Care AG & Co KGaA. To summarize, we found that Fresenius Medical Care AG & Co KGaA ranked in the 87th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Fresenius Medical Care AG & Co KGaA, consider:
- 49% of the company's capital comes from equity, which is greater than just 15.33% of stocks in our cash flow based forecasting set.
- Fresenius Medical Care AG & Co KGaA's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 1.98% of tickers in our DCF set.
- Relative to other stocks in its sector (Healthcare), Fresenius Medical Care AG & Co KGaA has a reliance on debt greater than 91.81% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 620% |
| 1% | 627% |
| 2% | 635% |
| 3% | 642% |
| 4% | 649% |
| 5% | 656% |
Want more companies with a valuation profile/forecast similar to that of Fresenius Medical Care AG & Co KGaA? See SXTC, FGEN, GTS, ASNB, and EBS.
Latest FMS News From Around the Web
Below are the latest news stories about Fresenius Medical Care AG & Co KGaA that investors may wish to consider to help them evaluate FMS as an investment opportunity.
German shares lose 0.61 pct FridayFRANKFURT, July 30 (Xinhua) -- German shares lost on Friday, with the benchmark DAX index down 96.08 points, or 0.61 percent, to close at 15,544.39 points. Renal dialysis equipment supplier Fresenius Medical lost the most among the blue chips, down by 4.53 percent, followed by European health care company Fresenius SE and Deutsche Post, which lost 3.93 percent and 2.11 percent respectively. Multinational |
ExThera Medical Corporation: ExThera Expands Distribution of Blood Purification and Pathogen Reduction Treatment for Sepsis and COVID-19 in EuropeExThera Medical and Fresenius Medical Care to offer Seraph 100 Microbind Affinity Filter in Turkey, Finland, and Estonia ExThera Medical, maker of the only effective pathogen-removal, hemoperfusio |
Clinical Diagnostics Devices Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Medtronic Inc, Boston Scientific, Fresenius Medical Care AG & Co. KGAA, Siemens AG,This report studies the Clinical Diagnostics Devices Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Clinical Diagnostics Devices market segmented by company, [] |
Plasma Component Separator Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:B Braun Melsungen, Haemonetics, Fresenius Medical Care, Toray Medical, Terumo, KawasuThis report studies the Plasma Component Separator Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Plasma Component Separator market segmented by company, [] |
UPS Healthcare Announces Agreement With Fresenius Medical Care, Expanding Service In The UKLONDON and BAD HOMBURG, Germany, July 22, 2021 /PRNewswire/ -- UPS Healthcare''s UK operation, Polar Speed, today announced a five-year commercial agreement with Fresenius Medical Care, a leading i |
FMS Price Returns
| 1-mo | -6.11% |
| 3-mo | -2.72% |
| 6-mo | 12.48% |
| 1-year | -10.10% |
| 3-year | -20.24% |
| 5-year | -11.42% |
| YTD | -6.25% |
| 2020 | 14.17% |
| 2019 | 15.01% |
| 2018 | -37.85% |
| 2017 | 25.49% |
| 2016 | 1.62% |
FMS Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching FMS
Want to see what other sources are saying about Fresenius Medical Care AG & Co KGaA's financials and stock price? Try the links below:Fresenius Medical Care AG & Co KGaA (FMS) Stock Price | Nasdaq
Fresenius Medical Care AG & Co KGaA (FMS) Stock Quote, History and News - Yahoo Finance
Fresenius Medical Care AG & Co KGaA (FMS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...